IL1B and COVID-19: A reverse assessment in a case–control study of COVID-19 showed increased salivary IL-6 measured at two time points in individuals with both COVID-19 and periodontitis, while periodontitis was associated with elevated salivary levels of RANKL and IL-1β [241].